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Encapsulation of drug molecules in particulate carriers as a method of controlled
delivery of molecules has been studied extensively. In recent years, a number of differ-
ent particulate systems, such as microcapsules and microspheres, have been proposed
and used in topical formulations as drug carrier vehicles. It has been claimed that these
new drug vehicles can improve and control drug release from conventional topical for-
mulations (1). Furthermore, the massage effect of these particles on the skin can have
cleansing and stimulating effects (2). With such devices, drugs can be effectively deli-
vered to the upper skin layers (viable epidermis) without penetration into deeper layers.
Therefore, microencapsulation reduces systemic uptake of active agents and supplies
drug molecules to the skin over a prolonged period of time (3). It has been shown that
reduction of either the applied dose or the frequency of administration give better phar-
macological results compared to administration of conventional doses of drugs (3).
This study deals with microencapsulation of lactic acid as an anti-ageing agent. Lactic
acid, an -hydroxy acid (AHA), is used to combat the visible effects of ageing. It produ-
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In this study, gelatin microspheres containing lactic acid
were prepared by the polymerization technique using glu-
taraldehyde as the cross-linking agent. Dried microsphe-
res were loaded by immersing them in an aqueous solu-
tion of lactic acid. In order to prepare microspheres with
an appropriate drug release profile, the effect of time of
cross-linking and the amount of cross-linking agent on
the swelling properties of microspheres and their release
profile were investigated. The microencapsulation effici-
ency, microspheres appearance, particle size, swelling ratio
and drug release profile were also studied. Microspheres
prepared with a larger amount of cross-linking agent, or
after longer cross-linking time, showed a reduced swelling
ratio in aqueous media. In vitro release pattern of lactic
acid from gelatin microspheres showed a biphasic profile
and the release rates were reduced upon increasing the amo-
unt of cross-liking agent and prolonging the cross-linking
time.
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ces more skin hydration than other -hydroxy acids and smoothes the lines and wrinkles
of the skin (4). Natural polymers such as gelatin have been widely used for the prepara-
tion of particulate drug delivery systems. Use of gelatin in pharmaceutics is particularly
attractive by virtue of its biocompatibility and biodegradability along with a total ab-
sence of toxicity or allergic problems (5). It has been utilized in the fabrication of both in-
jectable and oral drug delivery systems (6–10). Being a soluble polymer, gelatin has to be
chemically cross-linked to become insoluble at 37 °C. Aldehyde derivatives such as form-
aldehyde, glutaraldehyde or other bifunctional reactants have been used to produce in-
soluble biodegradable gelatin microspheres (11). Glutaraldehyde is used as a cross-
-linking agent to obtain rigid microspheres. This method has been widely studied in var-
ious formulations by different researchers (9, 12). Glutaraldehyde is expected to produce
cross-links between gelatin molecules and thereby to slow down the rate of drug release
from microspheres (13). In this method, it is important to remove excess oil by washing
the particles with solvents such as acetone. Otherwise, the oil retained in the microsphe-
res may cause aggregation and alter the morphological properties of the microspheres.
This washing procedure is also said to remove excess of the cross-linking agent (14). Ac-
etone, used to remove excess glutaraldehyde, extracts the water content of microspheres
to obtain hardened microspheres that are easily filtered and dried.
In a previous study, we investigated the effect of different formulation variables on
the particle size of gelatin microspheres containing lactic acid (15). In this study, the ef-
fect of cross-linking on the release profile of gelatin microspheres is reported. Impact of
both the duration of cross-linking reaction and the amount of cross-linking agent on the
swelling and drug release properties of microspheres is reported.
EXPERIMENTAL
Materials
Gelatin (food grade, NF), lactic acid (90%), glutaraldehyde, toluene, acetone, span
80, sulfuric acid and copper sulphate (CuSO4  5H2O) were purchased from Merck (Ger-
many). Sesame oil was purchased from Aseel (United Arab Emirates). 4-Hydroxy biphe-
nyl was obtained from Fluka (Switzerland).
Preparation of gelatin microspheres
Gelatin microspheres were prepared using an overhead stirrer with a five-blade pad-
dle (diameter 50 mm) (15). Five mL of gelatin solution (20%, m/V, in water) was preheated
to 80 °C and added drop-wise to 70 mL of sesame oil (viscosity 43.4 mPa s at 20 °C) con-
taining 1% (m/m) Span 80 (with respect to the mass of the oil phase) warmed to the same
temperature. The biphasic system was stirred under turbulent flow conditions using an
overhead stirrer (RW20DZM.n, IKA Labortechnik, Germany) to form a w/o emulsion. Glu-
taraldehyde-saturated toluene was prepared by mixing equal volumes of glutaraldehyde
and toluene in a decantation funnel. After shaking for 10 minutes, the mixture was al-
lowed to separate. The upper toluene layer saturated with glutaraldehyde was separated
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and added to the w/o emulsion. The dispersion was mixed for various time intervals at
an appropriate speed (1200 rpm).
Microspheres were then separated by decantation and washed free of oil with 20
mL of toluene for 2 min at 1500 rpm. The microspheres were then washed and dehy-
drated 3 times with 20 mL of acetone at 2000 rpm. Finally, microspheres were allowed to
dry at room temperature (25 °C). Upon drying, a yellow to yellowish orange colored free
flowing, fine powder was obtained. The gelatin microspheres were observed by both op-
tical microscopy (B3050 Prior, Prior Scientific, UK) and scanning electron microscopy
(Leica Manuf. Cambridge S 360, UK).
Loading of lactic acid
Lactic acid loading was carried out using the drug uptake method. One gram of
dried microspheres was allowed to swell in 40 mL solution of 90% lactic acid at 37 ± 0.2
°C for 30 min under continuous magnet stirring. Microspheres were then rapidly col-
lected using paper filtration, washed with water and acetone, and dried at room tempera-
ture. Microencapsulation efficiency or the total drug content, expressed as percentage, is
defined as the ratio of the mass of drug encapsulated within the microspheres to the to-
tal mass of microspheres.
Particle size measurement
Microspheres diameter and size distribution were measured by laser light diffracto-
metry equipment (Mastersizer X, Malvern Instrument, UK). The average particle size
was expressed as the volume mean diameter in micrometers.
Determination of the swelling ratio
The swelling ratio of gelatin microspheres was determined using a Laser particle
sizer (Analysette 22 Fritsch, Germany). Doubly distilled water was used as the swelling
medium. Microspheres were left in swelling medium for at least 60 min to reach maxi-
mum swelling. Volumetric measurements were made by measuring the diameters of mi-
crospheres placed in the swelling medium at appropriate time intervals. The swelling ra-
tio was calculated from the ratio of the volume of swollen particles to that of dry particles.
Drug content in microspheres
Microspheres (100 mg) were crushed in a porcelain mortar and then suspended in
50 mL of doubly distilled water. The amount of lactic acid released after 24 hours was
evaluated as the amount of the drug loaded in microspheres. No more drug release was
observed after 24 hours. Colorimetric method was used to measure the amount of lactic
acid (16); acetaldehyde produced by the reaction between lactic acid and hot sulfuric acid
was measured. Acetaldehyde reacted with copper and 4-hydroxy biphenyl and gave a
chromogen with an absorption peak at 570 nm (Spectronic plus, Milton Roy, USA). The
amount of lactic acid was calculated from the standard calibration curve. All experi-
ments were carried out in triplicate.
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In vitro drug release
Microspheres (100 mg) were placed in a container and immersed in 100 mL of dou-
bly distilled water at 37 ± 0.5 °C under continuous magnet stirring. Filtrate (5 mL) was
withdrawn at appropriate time intervals and the concentration of lactic acid was deter-
mined as stated above. To maintain a constant volume, 5 mL of water were returned to
the container.
Statistical analysis
The effect of cross-linking time and the amount of cross-linking agent on the lactic
acid release from gelatin microspheres were analyzed separately using Repeated Mea-
sures Analysis of Variance. When significant differences between the formulations were
observed, multiple comparisons by the Duncan test were applied.
RESULTS AND DISCUSSION
The mean particle size of microspheres prepared in this study was in the range of 10
to 1000 µm. Fig. 1 shows a typical particle size distribution. The prepared microspheres
were a free flowing, yellow colored powder. The color of the microspheres changed from
yellow to yellowish orange and to brown when cross-linking time and concentration of
glutaraldehyde-saturated toluene increased. This phenomenon may be caused by increas-
ing the degree of gelatin cross-linking.
Fig. 2 shows the SEM photographs of the gelatin microspheres treated with glutar-
aldehyde. As can be seen, spherical microspheres with a very smooth and uniform surface
were formed. No physical pores on the surface of the microspheres are seen. Appear-
ance of the microspheres surface and their mean particle size were only slightly affected
by the experimental cross-linking conditions (time and amount of the cross-linking agent).
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Fig. 1. Particle size distribution of gelatin
microspheres.
The swelling ratio of different formulations of gelatin microspheres was investiga-
ted as a function of the glutaraldehyde content and cross-linking time. As shown in Fig.
3, the swelling ratio of microspheres increased dramatically when a smaller amount of
cross-linking agent was used. The same pattern was observed when the duration of cross-
-linking was altered, i.e., the longer the time of cross-linking the lower was the ratio of
swelling. When microspheres were prepared during the cross-linking time of 1, 4 and 12
hours, their mean swelling ratio (± SD) was 8.34 ± 0.42, 4.51 ± 0.21 and 1.44 ± 0.09, re-
spectively. The mean swelling ratio (± SD) of microspheres was 6.31 ± 0.29, 4.51 ± 0.23
and 3.09 ± 0.18 when concentrations of 12, 21 and 35% (V/V) of glutaraldehyde-satu-
rated toluene were used, respectively.
In the presence of lactic acid, gelatin cross-linking using glutaraldehyde is not pos-
sible. Therefore, gelatin microspheres were first prepared and cross-linked and then load-
ed with lactic acid. Drug loading after microspheres preparation is also advantageous
since impurities associated with the microsphere preparation process may be removed
prior to loading.
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Fig. 2. Scanning electron micrographs of gelatin microspheres.












































Fig. 3. Effect of: a) cross-linking time, b) concentration of cross-linking agent (glutaraldehyde) on
mean swelling ratio (± SD) of gelatin microspheres. The experiment was repeated 3 times. SD is
represented as error bar.
Fig. 4 shows the optical micrograph of gelatin microspheres swelled in lactic acid.
Drug loading may be carried out under aqueous conditions when needed (17).
Table I shows the effect of the amount of acetone, used as washing agent, on the
microspheres, particle size and drug loading. As can be seen, the mean particle size for
drug loaded microspheres washed with a smaller quantity of acetone was larger than for
the others. This increase in mean particle size can be attributed to agglomeration of the
small sized microspheres, as observed under the microscope. Use of smaller quantities
of acetone as dehydrating solvent, increased the drug loading efficiency of microsphe-
res; low microencapsulation efficiencies were observed when a large quantity of acetone
was used. This phenomenon may be caused by the high solubility of lactic acid in hy-
drophilic solvents such as acetone. It may also be assumed that lactic acid molecules are
not fully encapsulated by the gelatin walls of microcapsules, but they are attached to the
gelatin surface of microspheres. Since lactic acid is freely soluble in acetone, a small
amount of acetone is capable to dissolve a substantial amount of lactic acid. By increas-
ing the quantity of acetone, microencapsulation efficiency was decreased. Reduced mi-
croencapsulation efficiency due to the solvent effect was earlier reported for alginate
microspheres using isopropanol as the dehydrating solvent (18), for apomorphine hy-
drochloride gelatin microspheres using acetone as the dehydrating and drug washing
solvent (19), and for collagen-gelatin microspheres containing deoxyuridine during wa-
shing with water (20).
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Fig. 4. Optical micrograph of gelatin microspheres: a) without lactic acid, not swelled, b) with
lactic acid, swelled during drug loading. Magnification: 400.
a) b)
Table I. Effect of the volume of acetonea on drug loading and the mean particle size of microspheresb




a Used as washing solvent for gelatin microspheres.
b Cross-linked with glutaraldehyde-saturated toluene (35%, V/V, glutaraldehyde) for 4 hours.
The amount of drug loaded was calculated using the standard calibration curve (R
= 0.9995). The percentage loading of lactic acid into microspheres was found to be 44 ±
3% when 50 mL of acetone was used for final washing of drug loaded microspheres. The
drug content of microspheres was slightly affected by the amount of the cross-linking
agent, whereas no difference in drug loading was observed as the cross-linking time pe-
riod increased. The release profiles of lactic acid from gelatin microspheres cross-linked
using different amounts of glutaraldehyde-saturated toluene or during different cross-
-linking time periods are displayed in Fig. 5. Microspheres maintained their spherical
shape even after 24 hours of release period. A biphasic pattern of drug release was ob-
served for all samples. Thus, regardless of the conditions of the cross-linking of gelatin
microspheres, an initial burst release was observed. Within the first hour, 40–80% of the
loaded drug was released. This burst release was followed by a prolonged period, dur-
ing which slower drug release took place. For batches cross-linked with 35% (V/V) glu-
taraldehyde-saturated toluene and 4 hours of cross-linking time period, t50% and t85% of
drug release were 40 and 480 minutes, respectively. This type of release profile is of in-
terest because the initial burst release can provide the initial penetration of lactic acid,
and the sustained release phase supplies the skin with the drug over a prolonged period
of time (21). The initial burst drug release may be attributed to the release of drug mole-
cules held loosely into or just beneath the surface of microspheres. Such a burst effect
was reported previously for gelatin microspheres (16, 19).
As shown in Fig. 5, by increasing the concentration of glutaraldehyde-saturated to-
luene from 12 to 35% (V/V), the amount of drug release decreased from 30 to 10% in the
first 30 minutes of the drug release experiment. It is also shown that by decreasing the
cross-linking time from 12 to 1 hour, the amount of drug release in the first 30 minutes of
drug release experiment increased by 12 to 42%. In the second phase, practically all the
drug was released from the microspheres cross-linked with either a smaller amount of
cross-linking agent or at various cross-linking time periods. However, only 82% of lactic
acid was released within 12 hours from gelatin microspheres cross-linked with 35% (V/V)
glutaraldehyde-saturated toluene.
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Fig. 5. In vitro release profile of lactic acid from gelatin microspheres prepared by: a) different
concentrations of cross-linking agent (glutaraldehyde), b) different cross-linking time periods.
The experiment was repeated 3 times. SD is represented as error bar.
Analysis by the Repeated Measures Analysis of Variance showed that the mean per-
centage of drug released in vitro from gelatin microspheres prepared with different amo-
unts of glutaraldehyde and during different cross-linking time periods differed signifi-
cantly (p < 0.005). This was confirmed by the Duncan test multiple comparison.
The rate constants for drug release were then computed for both the fast (first hour)
and slow release phases (Table II). It can be seen that the rate of drug release decreased
with increasing the glutaraldehyde content and cross-linking time for both the fast and
slow release phases. These results clearly indicate that the release of therapeutic agents
from gelatin microspheres can be controlled by varying these parameters.
Gelatin microspheres are known to swell in aqueous environments due to hydra-
tion. As a new polymeric structure is formed by introducing bridges between polymeric
chains during the cross-linking procedure, the extent of the swelling process depends on
the degree of cross-linking. Therefore, the denser the cross-linking bridges between the
gelatin molecules, the more packed is the structure. Such a structure can be character-
ized by lower and slower penetration of the solvent through the chain structure of the
polymer, suggesting that the swelling ratio and hence the release characteristics of the
microsphere can be controlled by varying the content of the cross-linking agent used
during the manufacturing process (19). Swelling of microspheres may result in mobility
of gelatin chains, facilitating rapid release rates of the drug by diffusion through the po-
lymer. Since glutaraldehyde is responsible for the formation of cross-links, increasing
the amount of glutaraldehyde and the cross-linking time will increase the polymer den-
sity, resulting in reduction of the macromolecular chains mobility, and the formation of
more stable and rigid spheres that show a lower tendency to swell. The finding of this
study is in agreement with Reddy and coworkers (7) and Chuo and coworkers (22) find-
ings, in which they reported that drug release from albumin microspheres could be ex-
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Table II. Rate constants for drug release for both fast and slow release phases for different formulations
Concentration of cross-linking agent
(%, V/V)














a First hour of drug release
b After the first hour of drug release
tended by increasing the cross-linking degree of microspheres. Likewise, Sahin and co-
workers (14) reported that a decrease in the swelling ratio in terbutaline sulphate loaded
albumin microspheres was observed with an increase in the glutaraldehyde concentra-
tion. Other researchers such as Raymond et al. (13) and Fan and Dash (9) have found
similar results. Raymond et al. (13) found out that the release of phenytoin sodium from
gelatin microspheres can be delayed by the addition of glutaraldehyde to the microsphere
formulation. Fan and Dash (9) also reported that increasing the glutaraldehyde concen-
tration decreased the release rate of doxorubicin from gelatin implants. As shown in this
study, this effect may be attributed to the fact that the cross--linking process usually
hardens the gelatin matrix and could also increase resistance for the penetration of re-
lease medium into the implant.
CONCLUSIONS
Spherical, lactic acid loaded gelatin microspheres were prepared by the chemical
cross-linking technique. In vitro drug release experiments showed a distinct biphasic re-
lease pattern that may be desirable for topical drug delivery, since a therapeutic loading
dose can be provided initially and the sustained drug release could maintain the thera-
peutic drug level. It can be concluded that the desired lactic acid release rate can be
achieved by controlling the amount of the cross-linking agent (glutaraldehyde) and the
duration of cross-linking time.
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S A @ E T A K
Priprava `elatinksih mikrosfera s mlije~nom kiselinom –
U~inak umre`avanja na osloba|anje ljekovite tvari
RASSOUL DINARVAND, SANAZ MAHMOODI, EFFAT FARBOUD, MASSOUD SALEHI i FATEMEH ATYABI
U radu je opisana priprava `elatinskih mikrosfera s mlije~nom kiselinom metodom
polimerizacije koriste}i glutaraldehid kao sredstvo za umre`avanje. Osu{ene mikrosfere
su uronjene u vodenu otopinu mlije~ne kiseline. Ispitivan je utjecaj vremena umre`ava-
nja i koli~ine sredstva za umre`avanje na bubrenje mikrosfera i njihov profil osloba|a-
nja. Tako|er je prou~avan izgled mikrosfera, veli~ina ~estica, bubrenje i profil osloba|a-
nja ljekovite tvari. Mikrosfere pripravljene s ve}im sadr`ajem sredstva za umre`avanje
ili uz produljeno vrijeme umre`avanja, u vodenom mediju manje bubre. Osloba|anje
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mlije~ne kiseline iz `elatinskih mikrosfera in vitro je bifazi~nog profila, a smanjuje se ako
je tijekom priprave pove}ana koli~ina sredstva za umre`avanje i produljeno vrijeme um-
re`avanja. Mikrosfere s odgovaraju}im profilom osloba|anja ljekovite tvari mogu se pri-
praviti pode{avanjem ta dva faktora tijekom priprave mikrosfera.
Klju~ne rije~i: mlije~na kiselina, mikrosfere, `elatina, umre`avanje
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